AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Carl Zeiss Meditec AG

Board/Management Information Sep 30, 2021

74_rns_2021-09-30_7ab4a272-b510-418a-b54f-d4ef723aca86.html

Board/Management Information

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 30 September 2021 16:20

Leadership Change in the Executive Board of Carl Zeiss Meditec AG

Carl Zeiss Meditec AG / Key word(s): Personnel

Leadership Change in the Executive Board of Carl Zeiss Meditec AG

30-Sep-2021 / 16:20 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


Leadership Change in the Executive Board of Carl Zeiss Meditec AG
Jena, September 30, 2021



The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has agreed on a change in the Executive Board of the company. Dr. Ludwin Monz, who has been Chief Executive Officer of the company since 2010, will turn over his position to Dr. Markus Weber, currently member of the Executive Board of Carl Zeiss AG, on December 31, 2021. The transition is happening on the best of terms and at Dr. Monz’ own request.



Dr. Weber has more than 20 years of experience in various management and research and development functions within the ZEISS Group and, on the Executive Board of Carl Zeiss AG, is currently responsible for the Semiconductor Technology segment. Along with his new role as Chief Executive Officer of Carl Zeiss Meditec AG, Dr. Weber will remain on the board of Carl Zeiss AG, assuming the responsibilities of Dr. Monz on that board, who will leave the Executive Board of Carl Zeiss AG on December 31, 2021.



In the view of the Supervisory Board of Carl Zeiss Meditec AG, management continuity is assured via the internal succession. The other two members of the Executive Board, Justus Felix Wehmer and Jan Willem de Cler, will remain in their current positions.

Contact for investors and press

Sebastian Frericks

Head of Investor Relations

Carl Zeiss Meditec AG

Tel.: +49 3641 220-116

E-Mail: [email protected]


30-Sep-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: [email protected]
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1237251
End of Announcement DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.